Ignite Creation Date:
2025-12-24 @ 12:21 PM
Ignite Modification Date:
2026-01-04 @ 9:15 AM
Study NCT ID:
NCT00126061
Status:
COMPLETED
Last Update Posted:
2015-01-16
First Post:
2005-08-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects
Sponsor:
Solvay Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
S219.3.117
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None